Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume $10.22 -0.57 (-5.28%) Closing price 07/3/2025 03:55 PM EasternExtended Trading$10.11 -0.11 (-1.08%) As of 07/3/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics Short Interest DataIndaptus Therapeutics (INDP) has a short interest of 748,000 shares, representing 5.80% of the float (the number of shares available for trading by the public). This marks a -26.67% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 62,271 shares to cover all short positions.Current Short Interest748,000 sharesPrevious Short Interest1,020,000 sharesChange Vs. Previous Month-26.67%Dollar Volume Sold Short$242.95 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares570,000 sharesFloat Size12,900,000 sharesShort Percent of Float5.80%Today's Trading Volume6,806 sharesAverage Trading Volume62,271 sharesToday's Volume Vs. Average11% Short Selling Indaptus Therapeutics? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025748,000 shares $242.95 thousand -26.7%5.8%0.1 $0.32 5/31/20251,020,000 shares $343.33 thousand +1,157.7%7.9%1.5 $0.34 5/15/202581,100 shares $34.06 thousand -32.4%0.6%0.2 $0.42 4/30/2025119,900 shares $55.15 thousand -8.5%0.9%0.3 $0.46 4/15/2025131,100 shares $66.11 thousand -40.7%1.0%0.3 $0.50 3/31/2025221,200 shares $121.64 thousand +322.1%1.9%0.6 $0.55 3/15/202552,400 shares $42.19 thousand -10.0%0.5%0.1 $0.81 2/28/202558,200 shares $48.83 thousand -25.9%0.5%2.5 $0.84 2/15/202578,500 shares $62.72 thousand +102.8%0.7%3.1 $0.80 1/31/202538,700 shares $35.22 thousand -41.7%0.4%1.6 $0.91 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202566,400 shares $57.77 thousand -11.2%0.7%0.6 $0.87 12/31/202474,800 shares $62.99 thousand -19.1%0.8%0.7 $0.84 12/15/202492,500 shares $92.50 thousand +0.5%1.0%0.8 $1.00 11/30/202492,000 shares $93.84 thousand +8.2%1.1%0.8 $1.02 11/15/202485,000 shares $94.35 thousand -38.7%1.1%0.8 $1.11 10/31/2024138,700 shares $162.28 thousand +348.9%1.9%1.3 $1.17 10/15/202430,900 shares $39.24 thousand -9.7%0.4%0.3 $1.27 9/30/202434,200 shares $42.41 thousand +284.3%0.5%2.5 $1.24 9/15/20248,900 shares $13.44 thousand +140.5%0.1%0.7 $1.51 8/31/20243,700 shares $6.10 thousand -47.9%0.1%0.3 $1.65 8/15/20247,100 shares $11.86 thousand -12.4%0.1%0.4 $1.67 7/31/20248,100 shares $16.52 thousand -42.6%0.1%0.4 $2.04 7/15/202414,100 shares $31.02 thousand +147.4%0.2%0.7 $2.20 6/30/20245,700 shares $12.08 thousand +9.6%0.1%0.2 $2.12 6/15/20245,200 shares $12.84 thousand -66.7%0.1%0.2 $2.47 5/31/202415,600 shares $36.97 thousand -6.0%0.3%0.5 $2.37 5/15/202416,600 shares $36.69 thousand -35.7%0.3%0.2 $2.21 4/30/202425,800 shares $55.99 thousand -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228.43 thousand -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224.22 thousand +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185.88 thousand +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73.70 thousand +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29.93 thousand +18.6%0.3%1.8 $1.74 1/31/202414,500 shares $23.93 thousand -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33.86 thousand -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36.08 thousand -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44.75 thousand -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52.43 thousand +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42.02 thousand +64.7%0.3%1 $2.20 10/31/202311,600 shares $26.45 thousand -3.3%0.2%0.5 $2.28Trump’s New Order Could Boost Social Security Benefits by 400% (Ad)If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.Click here to watch the full presentation before it's too late. 10/15/202312,000 shares $30.72 thousand -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38.57 thousand -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69.29 thousand -9.3%0.4%1 $3.38 8/31/202322,600 shares $64.86 thousand -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104.61 thousand +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44.92 thousand +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31.73 thousand -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32.47 thousand -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46.45 thousand -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43.85 thousand -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56.16 thousand -51.4%0.5%1 $2.08 4/30/202355,600 shares $145.06 thousand +159.8%1.0%2 $2.61 4/15/202321,400 shares $41.73 thousand -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43.66 thousand -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41.04 thousand +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45.15 thousand -21.3%0.5%1 $1.75 2/15/202332,800 shares $58.71 thousand -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69.21 thousand +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61.45 thousand -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77.87 thousand -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195 thousand +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30.42 thousand -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30.28 thousand +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30.38 thousand +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27.36 thousand -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38.45 thousand -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61.10 thousand -8.1%0.5%0.9 $2.68 8/31/202224,800 shares $62.50 thousand -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105.27 thousand -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163.30 thousand -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256.41 thousand +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134.15 thousand -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200.48 thousand -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460.71 thousand +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67.46 thousand -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129.21 thousand -14.7%0.8%1 $2.93 4/15/202251,700 shares $177.33 thousand -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252.40 thousand -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289.97 thousand +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313.50 thousand +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351 thousand -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531.93 thousand +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547.54 thousand +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229.71 thousand No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 748,000 shares of INDP short. 5.80% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.80% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a decrease in short interest in June. As of June 15th, there was short interest totaling 748,000 shares, a decrease of 26.7% from the previous total of 1,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 570,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 12,900,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 5.80% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Indaptus Therapeutics: Marinus Pharmaceuticals, Inc. (3.95%), Allakos Inc. (0.37%), Rani Therapeutics Holdings, Inc. (15.93%), MiNK Therapeutics, Inc. (1.08%), Dyadic International Inc. (0.72%), SCYNEXIS, Inc. (1.68%), China SXT Pharmaceuticals, Inc. (1.62%), Enlivex Therapeutics Ltd. (0.36%), FibroBiologics Inc. (4.92%), KALA BIO, Inc. (5.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies MRNS Short Interest Data ALLK Short Interest Data RANI Short Interest Data INKT Short Interest Data DYAI Short Interest Data SCYX Short Interest Data SXTC Short Interest Data ENLV Short Interest Data FBLG Short Interest Data KALA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDP Stock Alerts